Contributors | p. xix |
About this handbook | p. 3 |
Clinical Neuropsychology: General Issues | |
The Medical Chart: Efficient Information-Gathering Strategies and Proper Chart Noting | p. 9 |
The Chart Review | p. 10 |
The Progress Note | p. 14 |
The Future of Medical Records | p. 15 |
Conclusion | p. 16 |
The Neurological Examination | p. 17 |
Mental Status Examination | p. 18 |
Cranial Nerve Examination | p. 19 |
Motor System Examination | p. 22 |
Sensory Examination | p. 29 |
Conclusion | p. 32 |
Laboratory Testing in Neuropsychology | p. 34 |
Blood Tests | p. 35 |
Cerebrospinal Fluid Tests | p. 40 |
Urine Tests | p. 46 |
Electroencephalography | p. 47 |
Neuroimaging | p. 48 |
Use of Testing in Specific Psychiatric Presentations | p. 51 |
Conclusion | p. 54 |
Neuroimaging and Clinical Neuropsychological Practice | p. 56 |
Common Neuroimaging Methods | p. 57 |
Common Clinical Applications of Neuroimaging | p. 67 |
Pharmacological Applications of Neuroimaging | p. 71 |
Conclusion | p. 71 |
The Bedside Neuropsychological Examination | p. 75 |
Disorders of Common Referral Populations | p. 76 |
Reviewing the Medical Record | p. 79 |
Conducting the Bedside Examination | p. 81 |
Interpretation of Test Results and Rendering of the Final Diagnosis | p. 95 |
Conclusion | p. 95 |
Detecting Negative Response Bias and Diagnosing Malingering: The Dissimulation Exam | p. 102 |
Definition of Malingering | p. 103 |
Suspicion of Malingering | p. 104 |
Diagnosis | p. 105 |
Conclusion | p. 115 |
Neuropsychology and the Human Life Span | |
General Assessment Issues for a Pediatric Population | p. 123 |
Understanding Brain-Behavior Relationships in Children | p. 123 |
Medical and Neurological Disorders of Childhood | p. 124 |
Issues Particular to Pediatric Assessment | p. 124 |
Suggested Procedures for the Pediatric Evaluation | p. 130 |
Conclusion | p. 152 |
Age-Related Memory Impairment | p. 155 |
Definition of Age-Related Memory Impairment | p. 155 |
Functional Neuroanatomic Correlates of Memory Impairment in Older People | p. 168 |
Competing Diagnoses | p. 168 |
History | p. 169 |
Sensory, Motor, and Physical Symptoms | p. 170 |
Serology and Laboratory Results | p. 171 |
EEG and Neuroimaging | p. 171 |
The Neuropsychological Examination | p. 173 |
Key Neuropsychological Measures | p. 173 |
Psychiatric and Psychological Comorbidities | p. 174 |
Treatments | p. 180 |
Conclusion | p. 180 |
Late-Life Depression | p. 183 |
Defining Late-Life Depression | p. 183 |
Clinical Interventions for Late-Life Depression | p. 190 |
Neuropsychological Assessment of Patients With Late-Life Depression | p. 194 |
Conclusion | p. 203 |
The Dementias | p. 210 |
Background | p. 211 |
Neuropsychological Evaluation of Dementia | p. 219 |
Conclusion | p. 231 |
Neurological Disorders | |
Assessment of Movement and Demyelinating Disorders | p. 243 |
Movement Disorders | p. 244 |
Demyelinating Disorders | p. 268 |
Conclusion | p. 286 |
Cerebrovascular Disease | p. 294 |
Classification of Cerebrovascular Disease | p. 294 |
Functional Neuroanatomic Correlates | p. 297 |
Diagnoses to Rule Out | p. 299 |
Relevant Laboratory, Neuroradiological, and Electrophysiological Studies | p. 299 |
Standard Neuropsychological Assessment | p. 303 |
Alternative Neuropsychological Testing | p. 303 |
The Neurological Examination | p. 308 |
Treatment Issues | p. 310 |
Psychiatric Comorbidity Associated With Stroke | p. 313 |
Conclusion | p. 315 |
Epilepsy and Nonepileptic Seizure Disorders | p. 318 |
Epilepsy | p. 319 |
Nonepileptic Seizures | p. 337 |
Conclusion | p. 345 |
Traumatic Brain Injury and Postconcussion Syndrome | p. 351 |
Classification | p. 352 |
Neuroanatomical Correlates of TBI and Concussion | p. 361 |
Neurodiagnostic Data | p. 362 |
Neuropsychological Assessment | p. 363 |
Assessment of Noncognitive Symptoms | p. 371 |
Psychiatric and Psychosocial Sequelae | p. 372 |
Persistent Postconcussion Syndrome | p. 374 |
Conclusion | p. 377 |
Neurotoxicology | p. 381 |
Parameters of Exposure | p. 381 |
Frequently Encountered Neurotoxins | p. 382 |
Documenting Exposure | p. 386 |
Neuropsychological Changes Associated With Exposure | p. 389 |
Neurophysiological and Neuroimaging Techniques in Exposed Cases | p. 393 |
Conclusion | p. 394 |
Schizophrenia | p. 398 |
Diagnosis | p. 399 |
Developmental Process and Etiology | p. 399 |
Schizophrenia "Subtypes" | p. 400 |
Neuropathological-Neurochemical Correlates of Each Variant | p. 401 |
Functional Neuroanatomic Correlates | p. 402 |
Competing Diagnoses | p. 403 |
Diagnostic Clues From Medical History | p. 404 |
Sensory, Motor, and Other Physical Symptoms | p. 404 |
EEG and Neuroimaging Correlates | p. 405 |
Neuropsychological Examination | p. 405 |
Key Neuropsychological Measures Important to Differential Diagnosis | p. 408 |
Psychological/Psychiatric Comorbidity | p. 409 |
Treatment Alternatives | p. 410 |
Conclusion | p. 412 |
The Neuropsychology of Adult Neuro-Oncology | p. 415 |
Epidemiology | p. 415 |
Grading and Classification | p. 416 |
History and Neurological Examination | p. 418 |
Laboratory Studies | p. 421 |
Neuroimaging and Neuropathology | p. 421 |
Overview of Treatment Options | p. 424 |
Neuropsychological Evaluation | p. 425 |
Conclusion | p. 432 |
The Aphasias | p. 436 |
Etiology | p. 437 |
Functional Neuroanatomic Correlates of Aphasia | p. 438 |
Assessment of Aphasia | p. 439 |
Classic Aphasia Syndromes | p. 446 |
Other Aphasia Syndromes | p. 454 |
Distinguishing Aphasia From Other Disorders | p. 456 |
Key Neuropsychological Tests | p. 457 |
Conclusion | p. 458 |
Neurological Syndromes | |
Amnesic Syndromes | p. 463 |
Clinical Manifestations of Amnesia | p. 463 |
Neural Substrates of Amnesia | p. 469 |
Neuropsychological Evaluation | p. 475 |
Conclusion | p. 484 |
Neglect Syndromes | p. 489 |
Subtypes of Neglect | p. 489 |
Neuropathological Mechanisms Underlying Neglect | p. 493 |
Cognitive Mechanisms Underlying Neglect | p. 495 |
Differential Diagnosis | p. 497 |
Assessment for Neglect | p. 498 |
Associated Disorders | p. 503 |
Treatment | p. 504 |
Conclusion | p. 505 |
The Agnosias | p. 508 |
Basic Definitions | p. 509 |
Neuroanatomic Correlates | p. 516 |
Differential Diagnosis of Agnosia | p. 520 |
Relevant Laboratory, EEG, and Neuroimaging Correlates | p. 526 |
Psychological and Psychiatric Comorbidity | p. 528 |
Conclusion | p. 529 |
Limb Apraxias | p. 534 |
Types of Limb Apraxia | p. 535 |
The Examination for Limb Apraxia | p. 542 |
Types of Errors | p. 544 |
Conclusion | p. 544 |
Clinical Evaluation of Visual Perception and Constructional Ability | p. 547 |
Definition of Disorders in Visual Perception and Constructional Ability | p. 547 |
Functional Neuroanatomic Correlates | p. 562 |
Competing Diagnoses | p. 564 |
Relevant Medical History | p. 565 |
Sensory and Motor Correlates | p. 565 |
Laboratory Data | p. 566 |
Neuroimaging Correlates | p. 566 |
The Neuropsychological Examination | p. 566 |
Conclusion | p. 570 |
Disorders of Attention | p. 572 |
Components of Attention | p. 574 |
Functional Neuroanatomy of Attention | p. 579 |
Neurological and Neuropsychiatric Disorders of Attention | p. 582 |
Assessing Disorders of Attention | p. 586 |
Conclusion | p. 604 |
Frontal Lobe Function and Dysfunction | p. 607 |
Frontal Lobe Functions | p. 608 |
Frontal Lobe Dysfunction | p. 611 |
Diseases That Commonly Affect Frontal Functions | p. 613 |
Assessment of Frontal Lobe Functioning | p. 615 |
Cautions in Evaluating Frontal Functions | p. 621 |
Conclusion | p. 622 |
Adult Attention-Deficit/Hyperactivity Disorder | p. 626 |
Alternative Criteria for Diagnosing ADHD in Adults | p. 628 |
Functional Neuroanatomy | p. 632 |
Competing Diagnoses to Be Ruled Out | p. 633 |
Diagnostic Clues From Past History | p. 634 |
EEG and Neuroimaging Correlates | p. 636 |
Emphasis on Neuropsychological Assessment | p. 636 |
Key Tests and Measures | p. 638 |
Psychological and Psychiatric Co-Occurring Disorders | p. 639 |
Psychopharmacologic and Nonpharmacologic Treatments | p. 643 |
Conclusion | p. 644 |
Neuropsychology of Substance Use Disorders | p. 649 |
General Issues | p. 649 |
Alcohol | p. 656 |
Cannabis | p. 660 |
Cocaine | p. 662 |
Amphetamines and Methylendioxymethamphetamine (MDMA) | p. 663 |
Opioids | p. 666 |
Benzodiazepines | p. 668 |
Polysubstance Use | p. 669 |
Conclusion | p. 671 |
Emotional Disorders Associated With Neurological Diseases | p. 674 |
Definition of the Emotional Problem | p. 675 |
Development of Disruptions in Emotional Functioning | p. 677 |
Variants of Emotional Dysfunction | p. 677 |
Neuropathological Correlates of Dysfunction in the Perception, Expression, and Experience of Emotion | p. 678 |
Competing Diagnoses That Must Be Ruled Out | p. 682 |
The Neuropsychological Evaluation of Emotional Dysfunction | p. 683 |
Conclusion | p. 690 |
Selective Listing of Medical Record Abbreviations | p. 693 |
Index | p. 705 |
About the Editors | p. 767 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.